BCL-2 Inhibitor and Conventional Chemotherapy Combinations for Acute Myeloid Leukemia: Shifting From the Unfit to the Fit Patient With AML.
Gert OssenkoppeleParesh VyasPublished in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2020)